Prevention of recurrence of genital prolapse after surgical treatment Nervous System Diseases
Conditions
Interventions
The study aims to prevent the recurrence of genital prolapse after surgical treatment (anterior and posterior colpotomy, colporrhaphy with perineal levatorplasty) using a combination of a 6-month cour
Sponsors
Kazakhstan Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Anterior and posterior vaginal wall prolapse stage II, according to the Pelvic Organ Prolapse Quantification System (POP-Q) classification and stress-induced urinary incontinence stage III, which was determined by the classification of D.V. Kahn 2. Aged 45 years old and under 3. History of two or more labours 4. No consent for conservative treatment 5. No consent for use of vaginal synthetic prostheses, including urethral sling 6. No history of conservative treatment of prolapse, including pelvic floor muscles training 7. No history of metabolic diseases (diabetes mellitus, obesity, metabolic syndrome, thyroid gland disorders, calcium phosphate metabolism disorders)
Exclusion criteria
Exclusion criteria: 1. Urgent or combined urinary incontinence 2. Contraindications to surgical treatment and anaesthesia (general and regional anaesthesia: spinal, epidural anaesthesia) 3. Acute or chronic inflammatory diseases, acute phase of infectious diseases, malignant tumours, anaemia, benign ovarian and/or uterine tumours, pregnancy, haemorrhoids stage 3 and 4, decompensated chronic diseases, thrombosis and multiple drug allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of anatomical prolapse measured during gynecological examination using POP-Q international scale for the estimation of prolapse stage prior to treatment and 8 months after surgical operation | — |
Secondary
| Measure | Time frame |
|---|---|
| Helath-related quality of life measured using the Prolapse Quality of Life Questionnaire (P-QoL) in Russian and Kazakh languages prior to treatment and 8 months after treatment. | — |
Countries
Kazakhstan
Contacts
Public ContactBarmanasheva;Imasheva Zauresh;Bayan Imashkyzy
;
Outcome results
None listed